Distinct binding modes of a benzothiazole derivative provide the structural basis for gaining ERK2 or p38alpha selectivity
Hasegawa, S., Mayu, Y., Haruna, N., Hajime, S., Masaki, S., Kinoshita, T.To be published.
Experimental Data Snapshot
Starting Model: experimental
View more details
Entity ID: 1 | |||||
---|---|---|---|---|---|
Molecule | Chains | Sequence Length | Organism | Details | Image |
Mitogen-activated protein kinase 14 | 365 | Homo sapiens | Mutation(s): 0  Gene Names: MAPK14, CSBP, CSBP1, CSBP2, CSPB1, MXI2, SAPK2A EC: 2.7.11.24 | ||
UniProt & NIH Common Fund Data Resources | |||||
Find proteins for Q16539 (Homo sapiens) Explore Q16539  Go to UniProtKB:  Q16539 | |||||
PHAROS:  Q16539 GTEx:  ENSG00000112062  | |||||
Entity Groups   | |||||
Sequence Clusters | 30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity | ||||
UniProt Group | Q16539 | ||||
Sequence AnnotationsExpand | |||||
|
Ligands 1 Unique | |||||
---|---|---|---|---|---|
ID | Chains | Name / Formula / InChI Key | 2D Diagram | 3D Interactions | |
B8Z Query on B8Z | B [auth A] | ~{N}-(5,6-dimethoxy-1,3-benzothiazol-2-yl)-2-[(4-fluoranylphenoxy)methyl]-1,3-thiazole-4-carboxamide C20 H16 F N3 O4 S2 PCKXVDUIUFNAJD-UHFFFAOYSA-N |
Length ( Å ) | Angle ( ˚ ) |
---|---|
a = 45.366 | α = 90 |
b = 85.5 | β = 90 |
c = 125.669 | γ = 90 |
Software Name | Purpose |
---|---|
PHENIX | refinement |
PHENIX | refinement |
XDS | data reduction |
XDS | data scaling |
PHASER | phasing |
Funding Organization | Location | Grant Number |
---|---|---|
Not funded | -- |